Inivata Ltd:企業の製品パイプライン分析

◆英語タイトル:Inivata Ltd - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME2331550PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥192,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥288,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company’s product portfolio includes InVisionFirst – Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotide variants, insertions and deletions and structural variants in selected genes from DNA isolated from plasma samples from patients with non-small cell lung cancer; and InVisionSeq test. Inivata works with industry and academic researchers to develop new clinical applications for liquid biopsy and ctDNA analysis. The company operates in the UK and the US. Inivata is headquartered in Cambridge, Cambridgeshire, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Inivata Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Inivata Ltd Company Overview
Inivata Ltd Company Snapshot
Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview
Inivata Ltd – Pipeline Analysis Overview
Inivata Ltd – Key Facts
Inivata Ltd – Major Products and Services
Inivata Ltd Pipeline Products by Development Stage
Inivata Ltd Ongoing Clinical Trials by Trial Status
Inivata Ltd Pipeline Products Overview
InVision ctDNA Assay – EGFR-Mutant NSCLC
InVision ctDNA Assay – EGFR-Mutant NSCLC Product Overview
InVision ctDNA Assay – Metastatic Breast Cancer
InVision ctDNA Assay – Metastatic Breast Cancer Product Overview
InVision ctDNA Assay – NSCLC
InVision ctDNA Assay – NSCLC Product Overview
InVision ctDNA Assay – NSCLC Clinical Trial
InVision ctDNA Assay – Pancreatic Cancer
InVision ctDNA Assay – Pancreatic Cancer Product Overview
InVision ctDNA Assay – Stage III/IV NSCLC
InVision ctDNA Assay – Stage III/IV NSCLC Product Overview
Inivata Ltd – Key Competitors
Inivata Ltd – Key Employees
Inivata Ltd – Locations And Subsidiaries
Head Office
Recent Developments
Inivata Ltd, Recent Developments
Feb 27, 2020: Inivata’s Nitzan Rosenfeld to receive 2020 Cancer Researcher Award from the European Association for Cancer Research and Pezcoller Foundation
Oct 30, 2019: Inivata’s InVisionFirst-Lung test to be used for EORTC study
Oct 08, 2019: Novel approach based on InVision liquid biopsy platform predicts response to immune checkpoint inhibitors
Aug 29, 2019: Inivata to present new clinical data on the utility of liquid biopsy and InVisionFirst-Lung at World Conference on Lung Cancer 2019
Aug 12, 2019: Inivata appoints Jacqui Watson as Chief People Officer
Jul 18, 2019: Inivata announces launch of clinical trial to evaluate impact of InVisionFirst-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer
Apr 26, 2019: Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst-Lung liquid biopsy test
Apr 16, 2019: Genomics England and industry partners complete first phase of liquid biopsy study
Mar 07, 2019: Inivata publishes positive results of clinical validation and utility study for InVision Liquid Biopsy Test
Mar 05, 2019: Inivata receives medicare final coverage decision for InVisionFirst-Lung Liquid Biopsy test in advanced Non-Small Cell Lung Cancer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview
Inivata Ltd Pipeline Products by Equipment Type
Inivata Ltd Pipeline Products by Indication
Inivata Ltd Ongoing Clinical Trials by Trial Status
Inivata Ltd, Key Facts
Inivata Ltd, Major Products and Services
Inivata Ltd Number of Pipeline Products by Development Stage
Inivata Ltd Pipeline Products Summary by Development Stage
Inivata Ltd Ongoing Clinical Trials by Trial Status
Inivata Ltd Ongoing Clinical Trials Summary
InVision ctDNA Assay - EGFR-Mutant NSCLC - Product Status
InVision ctDNA Assay - EGFR-Mutant NSCLC - Product Description
InVision ctDNA Assay - Metastatic Breast Cancer - Product Status
InVision ctDNA Assay - Metastatic Breast Cancer - Product Description
InVision ctDNA Assay - NSCLC - Product Status
InVision ctDNA Assay - NSCLC - Product Description
InVision ctDNA Assay - NSCLC - Feasibility Study of PD-L1 Expression Analysis on Circulating Tumor Cells by Immunocytochemistry and MDSCs Level Evolution Analysis in Non-small Cell Lung Cancer Treated with PD-L1 or PD1 Inhibitor
InVision ctDNA Assay - NSCLC - Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation: LIBERTI
InVision ctDNA Assay - Pancreatic Cancer - Product Status
InVision ctDNA Assay - Pancreatic Cancer - Product Description
InVision ctDNA Assay - Stage III/IV NSCLC - Product Status
InVision ctDNA Assay - Stage III/IV NSCLC - Product Description
Inivata Ltd, Key Employees
Glossary

★海外企業調査レポート[Inivata Ltd:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Swissquote Group Holding Ltd (SQN):企業の財務・戦略的SWOT分析
    Swissquote Group Holding Ltd (SQN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Axalta Coating Systems Ltd:企業の戦略・SWOT・財務情報
    Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • National Bank Of Bahrain Bsc:企業の戦略・SWOT・財務分析
    National Bank Of Bahrain Bsc - Strategy, SWOT and Corporate Finance Report Summary National Bank Of Bahrain Bsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bega Cheese Ltd:企業のM&A・事業提携・投資動向
    Bega Cheese Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bega Cheese Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Kerry Group plc:戦略・SWOT・企業財務分析
    Kerry Group plc - Strategy, SWOT and Corporate Finance Report Summary Kerry Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Aileron Therapeutics Inc (ALRN)-製薬・医療分野:企業M&A・提携分析
    Summary Aileron Therapeutics Inc (Aileron) is a biopharmaceutical company that develops and commercializes novel class of therapeutics. The company provides products such as stapled peptide drugs. Its stapled peptides penetrate cells throughout the body and modulate intracellular protein-protein int …
  • Peregrine Pharmaceuticals Inc (PPHM)-製薬・医療分野:企業M&A・提携分析
    Summary Peregrine Pharmaceuticals Inc (Peregrine) is a biopharmaceutical company that develops and manufactures monoclonal antibodies for the treatment and diagnosis of cancer. The company’s products include Bavituximab, PGN650 and Cotara. Its Bavituximab is a monoclonal antibody that binds to a bas …
  • Applied Industrial Technologies, Inc.:企業の戦略・SWOT・財務分析
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • StemBioSys Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary StemBioSys Inc (StemBioSys) is a biomedical company that concentrates on isolation, expansion and delivery of specialized adult stem cells. The company has developed high performance microenvironment for treating human diseases. Its HPME is an advanced stem cell culture system that creates n …
  • Hollister Inc:企業の戦略的SWOT分析
    Hollister Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • America Movil SAB DE CV (AMXL):企業の財務・戦略的SWOT分析
    America Movil SAB DE CV (AMXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Fast Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    Fast Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fast Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • bioMerieux SA (BIM)-医療機器分野:企業M&A・提携分析
    Summary bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiov …
  • Cable & Wireless Communications Ltd:企業の戦略的SWOT分析
    Cable & Wireless Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Cracker Barrel Old Country Store, Inc. (CBRL):企業の財務・戦略的SWOT分析
    Cracker Barrel Old Country Store, Inc. (CBRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Klaria Pharma Holding AB (KLAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Klaria Pharma Holding AB (Klaria Pharma) is a developer of fast acting medicinal products that designes, develops and commercializ therapeutics for migraine and cancer related pain. The company’s patented drug delivery platform is an alginate-based polymer film, facilitates quick and dependa …
  • Nippon Paint (China) Co Ltd:企業の戦略・SWOT・財務情報
    Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Clalit Health Services:企業の戦略的SWOT分析
    Clalit Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Arabtec Holding:企業の戦略・SWOT・財務情報
    Arabtec Holding - Strategy, SWOT and Corporate Finance Report Summary Arabtec Holding - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆